

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 8.76457608 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 8.27371728 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.67974157 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.67974157 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.33432090 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.33432090 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.96652454 |
| 8 | drug metabolic process (GO:0017144) | 6.37385649 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.34395333 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.34395333 |
| 11 | tryptophan catabolic process (GO:0006569) | 6.34395333 |
| 12 | kynurenine metabolic process (GO:0070189) | 6.14386545 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.11917026 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.99988308 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.96848623 |
| 16 | oxidative demethylation (GO:0070989) | 5.88068105 |
| 17 | urea cycle (GO:0000050) | 5.63678871 |
| 18 | urea metabolic process (GO:0019627) | 5.63678871 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.60592932 |
| 20 | cysteine metabolic process (GO:0006534) | 5.53881804 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.45043464 |
| 22 | * glyoxylate metabolic process (GO:0046487) | 5.41277715 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.34328473 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 5.34151126 |
| 25 | phenylpropanoid metabolic process (GO:0009698) | 5.34029124 |
| 26 | ethanol metabolic process (GO:0006067) | 5.31287746 |
| 27 | complement activation, alternative pathway (GO:0006957) | 5.29385502 |
| 28 | regulation of protein activation cascade (GO:2000257) | 5.28211291 |
| 29 | regulation of fibrinolysis (GO:0051917) | 5.26593818 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.25949696 |
| 31 | protein carboxylation (GO:0018214) | 5.25949696 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 5.22080437 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 5.19139356 |
| 34 | bile acid metabolic process (GO:0008206) | 5.09400318 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 5.05952601 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.05781125 |
| 37 | regulation of plasminogen activation (GO:0010755) | 5.00863504 |
| 38 | homocysteine metabolic process (GO:0050667) | 4.94013272 |
| 39 | regulation of complement activation (GO:0030449) | 4.93486755 |
| 40 | lysine catabolic process (GO:0006554) | 4.91328104 |
| 41 | lysine metabolic process (GO:0006553) | 4.91328104 |
| 42 | tyrosine metabolic process (GO:0006570) | 4.82310999 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 4.71406139 |
| 44 | amino-acid betaine metabolic process (GO:0006577) | 4.70514385 |
| 45 | negative regulation of blood coagulation (GO:0030195) | 4.67619803 |
| 46 | negative regulation of hemostasis (GO:1900047) | 4.67619803 |
| 47 | * alpha-amino acid catabolic process (GO:1901606) | 4.66954740 |
| 48 | regulation of cholesterol esterification (GO:0010872) | 4.66506615 |
| 49 | reverse cholesterol transport (GO:0043691) | 4.65884488 |
| 50 | plasma lipoprotein particle remodeling (GO:0034369) | 4.59644810 |
| 51 | protein-lipid complex remodeling (GO:0034368) | 4.59644810 |
| 52 | macromolecular complex remodeling (GO:0034367) | 4.59644810 |
| 53 | negative regulation of protein activation cascade (GO:2000258) | 4.57949741 |
| 54 | triglyceride homeostasis (GO:0070328) | 4.54282171 |
| 55 | acylglycerol homeostasis (GO:0055090) | 4.54282171 |
| 56 | response to mercury ion (GO:0046689) | 4.52355957 |
| 57 | flavonoid metabolic process (GO:0009812) | 4.50937539 |
| 58 | negative regulation of sterol transport (GO:0032372) | 4.50920981 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 4.50920981 |
| 60 | S-adenosylmethionine metabolic process (GO:0046500) | 4.50841120 |
| 61 | indolalkylamine metabolic process (GO:0006586) | 4.50034950 |
| 62 | cellular ketone body metabolic process (GO:0046950) | 4.49139861 |
| 63 | acute-phase response (GO:0006953) | 4.45441775 |
| 64 | coenzyme catabolic process (GO:0009109) | 4.42071728 |
| 65 | phospholipid efflux (GO:0033700) | 4.40656693 |
| 66 | alkaloid metabolic process (GO:0009820) | 4.40079864 |
| 67 | cellular biogenic amine catabolic process (GO:0042402) | 4.39098240 |
| 68 | amine catabolic process (GO:0009310) | 4.39098240 |
| 69 | regulation of humoral immune response (GO:0002920) | 4.38833755 |
| 70 | bile acid and bile salt transport (GO:0015721) | 4.37617178 |
| 71 | glutamate metabolic process (GO:0006536) | 4.33408751 |
| 72 | * cellular amino acid catabolic process (GO:0009063) | 4.31152862 |
| 73 | cellular glucuronidation (GO:0052695) | 4.30783653 |
| 74 | imidazole-containing compound metabolic process (GO:0052803) | 4.30351238 |
| 75 | negative regulation of coagulation (GO:0050819) | 4.25958287 |
| 76 | negative regulation of wound healing (GO:0061045) | 4.23765591 |
| 77 | opsonization (GO:0008228) | 4.23602034 |
| 78 | plasma lipoprotein particle clearance (GO:0034381) | 4.21931508 |
| 79 | benzene-containing compound metabolic process (GO:0042537) | 4.21600068 |
| 80 | cellular modified amino acid catabolic process (GO:0042219) | 4.17316417 |
| 81 | drug catabolic process (GO:0042737) | 4.16662520 |
| 82 | ethanol oxidation (GO:0006069) | 4.16405094 |
| 83 | * serine family amino acid metabolic process (GO:0009069) | 4.12565604 |
| 84 | hormone catabolic process (GO:0042447) | 4.11267566 |
| 85 | * glycine metabolic process (GO:0006544) | 4.10660433 |
| 86 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.10513573 |
| 87 | cholesterol efflux (GO:0033344) | 4.07535816 |
| 88 | arginine metabolic process (GO:0006525) | 3.98923640 |
| 89 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.94752694 |
| 90 | intestinal cholesterol absorption (GO:0030299) | 3.92462139 |
| 91 | fibrinolysis (GO:0042730) | 3.91341244 |
| 92 | ketone body metabolic process (GO:1902224) | 3.88788915 |
| 93 | low-density lipoprotein particle remodeling (GO:0034374) | 3.87712518 |
| 94 | positive regulation of blood coagulation (GO:0030194) | 3.86085080 |
| 95 | positive regulation of hemostasis (GO:1900048) | 3.86085080 |
| 96 | glucuronate metabolic process (GO:0019585) | 3.85479734 |
| 97 | uronic acid metabolic process (GO:0006063) | 3.85479734 |
| 98 | plasma lipoprotein particle assembly (GO:0034377) | 3.85348254 |
| 99 | acetyl-CoA metabolic process (GO:0006084) | 3.81904919 |
| 100 | short-chain fatty acid metabolic process (GO:0046459) | 3.81723976 |
| 101 | * organic acid catabolic process (GO:0016054) | 3.78106255 |
| 102 | * carboxylic acid catabolic process (GO:0046395) | 3.78106255 |
| 103 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.76670158 |
| 104 | urate metabolic process (GO:0046415) | 3.75466460 |
| 105 | negative regulation of complement activation (GO:0045916) | 3.75171156 |
| 106 | cofactor catabolic process (GO:0051187) | 3.75041873 |
| 107 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.74765214 |
| 108 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.74765214 |
| 109 | regulation of bile acid biosynthetic process (GO:0070857) | 3.74045549 |
| 110 | blood coagulation, intrinsic pathway (GO:0007597) | 3.73142118 |
| 111 | complement activation, classical pathway (GO:0006958) | 3.72919064 |
| 112 | drug transmembrane transport (GO:0006855) | 3.71237790 |
| 113 | regulation of cholesterol homeostasis (GO:2000188) | 3.69600650 |
| 114 | phospholipid homeostasis (GO:0055091) | 3.69546734 |
| 115 | cytolysis (GO:0019835) | 3.69312006 |
| 116 | exogenous drug catabolic process (GO:0042738) | 3.69242967 |
| 117 | complement activation (GO:0006956) | 3.68193055 |
| 118 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.67968268 |
| 119 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.67968268 |
| 120 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.67303249 |
| 121 | cholesterol homeostasis (GO:0042632) | 3.67019431 |
| 122 | positive regulation of lipid catabolic process (GO:0050996) | 3.65236786 |
| 123 | heme transport (GO:0015886) | 3.65155863 |
| 124 | sodium-independent organic anion transport (GO:0043252) | 3.64967246 |
| 125 | protein activation cascade (GO:0072376) | 3.64764657 |
| 126 | aspartate family amino acid catabolic process (GO:0009068) | 3.62322618 |
| 127 | sterol homeostasis (GO:0055092) | 3.61947239 |
| 128 | * serine family amino acid biosynthetic process (GO:0009070) | 3.61809461 |
| 129 | xenobiotic metabolic process (GO:0006805) | 3.61339778 |
| 130 | negative regulation of lipase activity (GO:0060192) | 3.59885048 |
| 131 | positive regulation of coagulation (GO:0050820) | 3.56003839 |
| 132 | NAD biosynthetic process (GO:0009435) | 3.55694303 |
| 133 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.48779769 |
| 134 | proline metabolic process (GO:0006560) | 3.48615497 |
| 135 | acute inflammatory response (GO:0002526) | 3.47570116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.37598304 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.19964824 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.00395705 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.49978900 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.24736524 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.03125781 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.78728844 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.02069268 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.99632903 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.09860997 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.01785589 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9394879 |
| 13 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.96879048 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61811728 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56315498 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.52278704 |
| 17 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.42464136 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40878213 |
| 19 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.26573861 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20941667 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20092387 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.18590654 |
| 23 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15980373 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12169453 |
| 25 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03545597 |
| 26 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.03512543 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02810222 |
| 28 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.01591779 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99414360 |
| 30 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.98668970 |
| 31 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.98581404 |
| 32 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95503206 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.94807086 |
| 34 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.88490155 |
| 35 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.88348786 |
| 36 | NFYA_21822215_ChIP-Seq_K562_Human | 0.88086633 |
| 37 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.87670098 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.87126542 |
| 39 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.84598164 |
| 40 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.84242161 |
| 41 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83651404 |
| 42 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83384890 |
| 43 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82961641 |
| 44 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82801129 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.82259773 |
| 46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.82222240 |
| 47 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.79747090 |
| 48 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77509985 |
| 49 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.77415594 |
| 50 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77112145 |
| 51 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76335284 |
| 52 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.74156397 |
| 53 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73496495 |
| 54 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73283364 |
| 55 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.72246579 |
| 56 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.71943340 |
| 57 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71903046 |
| 58 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71398383 |
| 59 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.71221889 |
| 60 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.70974165 |
| 61 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.70429103 |
| 62 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70424896 |
| 63 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.68950509 |
| 64 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68637266 |
| 65 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.68246985 |
| 66 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.67808578 |
| 67 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67248574 |
| 68 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67248574 |
| 69 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.67200190 |
| 70 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.66824824 |
| 71 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.65719297 |
| 72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.65154924 |
| 73 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.64166272 |
| 74 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.63672737 |
| 75 | NFYB_21822215_ChIP-Seq_K562_Human | 0.63443033 |
| 76 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61956203 |
| 77 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.61931207 |
| 78 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61640774 |
| 79 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.61324692 |
| 80 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60407908 |
| 81 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60089715 |
| 82 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.59454206 |
| 83 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.59392256 |
| 84 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58086651 |
| 85 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.57507162 |
| 86 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.57254006 |
| 87 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.56666194 |
| 88 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.56564177 |
| 89 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.56097346 |
| 90 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.56016100 |
| 91 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.55136503 |
| 92 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.54743018 |
| 93 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.54508090 |
| 94 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.53955563 |
| 95 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.53934216 |
| 96 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.53601910 |
| 97 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.53515532 |
| 98 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53496734 |
| 99 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53454143 |
| 100 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.53429376 |
| 101 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53407972 |
| 102 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52674894 |
| 103 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.52195233 |
| 104 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.52131008 |
| 105 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51916700 |
| 106 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.51331947 |
| 107 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.51248816 |
| 108 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50166556 |
| 109 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.50025119 |
| 110 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49987732 |
| 111 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49922648 |
| 112 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48806859 |
| 113 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.47749630 |
| 114 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.46641686 |
| 115 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46452600 |
| 116 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45641483 |
| 117 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.45331582 |
| 118 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.45031503 |
| 119 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43305463 |
| 120 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.42342394 |
| 121 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42286479 |
| 122 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.41782006 |
| 123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41445715 |
| 124 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.41419613 |
| 125 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.41289626 |
| 126 | GATA1_19941826_ChIP-Seq_K562_Human | 0.40999538 |
| 127 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.40372077 |
| 128 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40107966 |
| 129 | GATA2_19941826_ChIP-Seq_K562_Human | 0.40033930 |
| 130 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.39215090 |
| 131 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.38774102 |
| 132 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.38559122 |
| 133 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38474853 |
| 134 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.37460133 |
| 135 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36785168 |
| 136 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35838156 |
| 137 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.35575370 |
| 138 | NCOR_22424771_ChIP-Seq_293T_Human | 0.35279500 |
| 139 | * EGR1_19032775_ChIP-ChIP_M12_Human | 0.34934693 |
| 140 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.34435410 |
| 141 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.34265195 |
| 142 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.33923360 |
| 143 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.33859269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.31733722 |
| 2 | MP0005360_urolithiasis | 7.68330979 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.40933467 |
| 4 | MP0005365_abnormal_bile_salt | 6.11696847 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.14226264 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.24534547 |
| 7 | MP0003252_abnormal_bile_duct | 3.97564403 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.49889248 |
| 9 | MP0009840_abnormal_foam_cell | 3.10943908 |
| 10 | MP0005083_abnormal_biliary_tract | 2.96342677 |
| 11 | MP0003195_calcinosis | 2.96009633 |
| 12 | MP0005332_abnormal_amino_acid | 2.90569237 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.58311450 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.30031318 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.23205409 |
| 16 | MP0000609_abnormal_liver_physiology | 2.13619063 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.10138192 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.08227035 |
| 19 | MP0003868_abnormal_feces_composition | 1.87298664 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.84471331 |
| 21 | MP0001764_abnormal_homeostasis | 1.66883058 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59356548 |
| 23 | MP0009697_abnormal_copulation | 1.51599197 |
| 24 | MP0005451_abnormal_body_composition | 1.44165515 |
| 25 | MP0009643_abnormal_urine_homeostasis | 1.37862144 |
| 26 | MP0003186_abnormal_redox_activity | 1.31068534 |
| 27 | MP0003011_delayed_dark_adaptation | 1.30823504 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.20324943 |
| 29 | MP0000598_abnormal_liver_morphology | 1.16701926 |
| 30 | MP0005647_abnormal_sex_gland | 1.12620275 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.10152648 |
| 32 | MP0009764_decreased_sensitivity_to | 1.06692471 |
| 33 | MP0005636_abnormal_mineral_homeostasis | 1.04694777 |
| 34 | MP0000604_amyloidosis | 1.02971279 |
| 35 | MP0002132_abnormal_respiratory_system | 1.02256397 |
| 36 | MP0009763_increased_sensitivity_to | 0.98794699 |
| 37 | MP0002254_reproductive_system_inflammat | 0.96876566 |
| 38 | MP0010368_abnormal_lymphatic_system | 0.91073903 |
| 39 | MP0008469_abnormal_protein_level | 0.88521939 |
| 40 | MP0009642_abnormal_blood_homeostasis | 0.87675511 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 0.85922927 |
| 42 | MP0005408_hypopigmentation | 0.85266914 |
| 43 | MP0003879_abnormal_hair_cell | 0.84843959 |
| 44 | MP0005670_abnormal_white_adipose | 0.81449269 |
| 45 | MP0002876_abnormal_thyroid_physiology | 0.81190893 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 0.80450149 |
| 47 | MP0005376_homeostasis/metabolism_phenot | 0.77964847 |
| 48 | MP0002078_abnormal_glucose_homeostasis | 0.77739916 |
| 49 | MP0009765_abnormal_xenobiotic_induced | 0.77366923 |
| 50 | MP0005220_abnormal_exocrine_pancreas | 0.74939813 |
| 51 | MP0005535_abnormal_body_temperature | 0.71553113 |
| 52 | MP0001756_abnormal_urination | 0.71347796 |
| 53 | MP0002971_abnormal_brown_adipose | 0.71275300 |
| 54 | MP0001661_extended_life_span | 0.69020533 |
| 55 | MP0005334_abnormal_fat_pad | 0.67540591 |
| 56 | MP0004130_abnormal_muscle_cell | 0.65861783 |
| 57 | MP0003690_abnormal_glial_cell | 0.64781534 |
| 58 | MP0001915_intracranial_hemorrhage | 0.64501002 |
| 59 | MP0005266_abnormal_metabolism | 0.63767004 |
| 60 | MP0005187_abnormal_penis_morphology | 0.61055676 |
| 61 | MP0009053_abnormal_anal_canal | 0.61049502 |
| 62 | MP0003329_amyloid_beta_deposits | 0.60985894 |
| 63 | MP0006035_abnormal_mitochondrial_morpho | 0.59765571 |
| 64 | MP0002282_abnormal_trachea_morphology | 0.59675129 |
| 65 | MP0002136_abnormal_kidney_physiology | 0.57083202 |
| 66 | MP0000639_abnormal_adrenal_gland | 0.55081531 |
| 67 | MP0002928_abnormal_bile_duct | 0.52222886 |
| 68 | MP0005448_abnormal_energy_balance | 0.51863416 |
| 69 | MP0003878_abnormal_ear_physiology | 0.50143540 |
| 70 | MP0005377_hearing/vestibular/ear_phenot | 0.50143540 |
| 71 | MP0005395_other_phenotype | 0.49839500 |
| 72 | MP0005464_abnormal_platelet_physiology | 0.48145374 |
| 73 | MP0002249_abnormal_larynx_morphology | 0.48066075 |
| 74 | MP0003638_abnormal_response/metabolism_ | 0.47466217 |
| 75 | MP0008874_decreased_physiological_sensi | 0.44824115 |
| 76 | MP0004043_abnormal_pH_regulation | 0.44292669 |
| 77 | MP0002822_catalepsy | 0.43909048 |
| 78 | MP0003724_increased_susceptibility_to | 0.43732485 |
| 79 | MP0003718_maternal_effect | 0.43298518 |
| 80 | MP0008873_increased_physiological_sensi | 0.43046203 |
| 81 | MP0005023_abnormal_wound_healing | 0.42722084 |
| 82 | MP0004782_abnormal_surfactant_physiolog | 0.42541538 |
| 83 | MP0003953_abnormal_hormone_level | 0.41653411 |
| 84 | MP0003183_abnormal_peptide_metabolism | 0.41438797 |
| 85 | MP0002837_dystrophic_cardiac_calcinosis | 0.41423989 |
| 86 | MP0004381_abnormal_hair_follicle | 0.39448417 |
| 87 | MP0005666_abnormal_adipose_tissue | 0.38869875 |
| 88 | MP0003075_altered_response_to | 0.38609042 |
| 89 | MP0005166_decreased_susceptibility_to | 0.38482334 |
| 90 | MP0009785_altered_susceptibility_to | 0.38440423 |
| 91 | MP0003436_decreased_susceptibility_to | 0.37935515 |
| 92 | MP0008872_abnormal_physiological_respon | 0.37849001 |
| 93 | MP0003959_abnormal_lean_body | 0.37846278 |
| 94 | MP0005248_abnormal_Harderian_gland | 0.37734856 |
| 95 | MP0009672_abnormal_birth_weight | 0.36472910 |
| 96 | MP0000230_abnormal_systemic_arterial | 0.36002474 |
| 97 | MP0002168_other_aberrant_phenotype | 0.35718689 |
| 98 | MP0002796_impaired_skin_barrier | 0.34948622 |
| 99 | MP0000579_abnormal_nail_morphology | 0.34277305 |
| 100 | MP0009384_cardiac_valve_regurgitation | 0.33337682 |
| 101 | MP0001765_abnormal_ion_homeostasis | 0.31637532 |
| 102 | MP0006082_CNS_inflammation | 0.31172979 |
| 103 | MP0009115_abnormal_fat_cell | 0.31024290 |
| 104 | MP0005058_abnormal_lysosome_morphology | 0.29956079 |
| 105 | MP0002970_abnormal_white_adipose | 0.29154502 |
| 106 | MP0000249_abnormal_blood_vessel | 0.28670404 |
| 107 | MP0000467_abnormal_esophagus_morphology | 0.28430554 |
| 108 | MP0005164_abnormal_response_to | 0.27829598 |
| 109 | MP0001845_abnormal_inflammatory_respons | 0.27393670 |
| 110 | MP0001243_abnormal_dermal_layer | 0.26799594 |
| 111 | MP0010386_abnormal_urinary_bladder | 0.26655163 |
| 112 | MP0001853_heart_inflammation | 0.26561509 |
| 113 | MP0001881_abnormal_mammary_gland | 0.26327195 |
| 114 | MP0002135_abnormal_kidney_morphology | 0.25771751 |
| 115 | MP0004883_abnormal_blood_vessel | 0.25102771 |
| 116 | MP0004272_abnormal_basement_membrane | 0.23296215 |
| 117 | MP0001986_abnormal_taste_sensitivity | 0.21997333 |
| 118 | MP0002332_abnormal_exercise_endurance | 0.21595737 |
| 119 | MP0003633_abnormal_nervous_system | 0.19703280 |
| 120 | MP0002089_abnormal_postnatal_growth/wei | 0.19109106 |
| 121 | MP0005409_darkened_coat_color | 0.18758850 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.35978567 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.25431978 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.19526786 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.57958164 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.37738839 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.25452105 |
| 7 | Xanthomatosis (HP:0000991) | 6.19972607 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.39369999 |
| 9 | Complement deficiency (HP:0004431) | 5.32110917 |
| 10 | Joint hemorrhage (HP:0005261) | 4.67336181 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.63129844 |
| 12 | Hyperammonemia (HP:0001987) | 4.62547571 |
| 13 | Hyperglycinemia (HP:0002154) | 4.53672481 |
| 14 | Epidermoid cyst (HP:0200040) | 4.45451704 |
| 15 | Ketosis (HP:0001946) | 4.36964559 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.35857249 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.33280574 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.26798958 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.24103311 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.20533430 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 4.17647377 |
| 22 | Hyperglycinuria (HP:0003108) | 4.15246854 |
| 23 | Fat malabsorption (HP:0002630) | 4.11559085 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 4.08789303 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.08789303 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 4.00448198 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.87892761 |
| 28 | Abnormality of complement system (HP:0005339) | 3.86492472 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.77967848 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.71692014 |
| 31 | Nephritis (HP:0000123) | 3.68202301 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.67560440 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.50963481 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.42840217 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.33612917 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.30443879 |
| 37 | Ketoacidosis (HP:0001993) | 3.21572504 |
| 38 | Delayed CNS myelination (HP:0002188) | 3.20755116 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.18961628 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.12857726 |
| 41 | Steatorrhea (HP:0002570) | 3.10611493 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 2.98621498 |
| 43 | Spontaneous abortion (HP:0005268) | 2.96738896 |
| 44 | Abnormality of purine metabolism (HP:0004352) | 2.89458518 |
| 45 | Hypochromic microcytic anemia (HP:0004840) | 2.88877937 |
| 46 | Myocardial infarction (HP:0001658) | 2.87717703 |
| 47 | Gout (HP:0001997) | 2.85627093 |
| 48 | Osteomalacia (HP:0002749) | 2.85499258 |
| 49 | Metabolic acidosis (HP:0001942) | 2.82669641 |
| 50 | Skin nodule (HP:0200036) | 2.74818307 |
| 51 | Hyperphosphaturia (HP:0003109) | 2.73345758 |
| 52 | Systemic lupus erythematosus (HP:0002725) | 2.71287933 |
| 53 | Vascular calcification (HP:0004934) | 2.68314720 |
| 54 | Lethargy (HP:0001254) | 2.66270599 |
| 55 | Dicarboxylic aciduria (HP:0003215) | 2.64525133 |
| 56 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.64525133 |
| 57 | Increased circulating renin level (HP:0000848) | 2.54856533 |
| 58 | Fair hair (HP:0002286) | 2.50622841 |
| 59 | Hypoglycemic seizures (HP:0002173) | 2.50598921 |
| 60 | Spastic diplegia (HP:0001264) | 2.49936536 |
| 61 | Acanthocytosis (HP:0001927) | 2.48232039 |
| 62 | Cerebral edema (HP:0002181) | 2.42832325 |
| 63 | Mitral stenosis (HP:0001718) | 2.41971983 |
| 64 | Abnormal gallbladder morphology (HP:0012437) | 2.41066826 |
| 65 | Irritability (HP:0000737) | 2.40998258 |
| 66 | Neonatal onset (HP:0003623) | 2.39491842 |
| 67 | Reduced antithrombin III activity (HP:0001976) | 2.39056362 |
| 68 | Cardiovascular calcification (HP:0011915) | 2.37738120 |
| 69 | Neonatal hypoglycemia (HP:0001998) | 2.35647888 |
| 70 | Elevated alkaline phosphatase (HP:0003155) | 2.35345357 |
| 71 | Malnutrition (HP:0004395) | 2.35309714 |
| 72 | Cholelithiasis (HP:0001081) | 2.35120182 |
| 73 | Glomerulonephritis (HP:0000099) | 2.34697412 |
| 74 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.31232803 |
| 75 | Abnormal urine phosphate concentration (HP:0012599) | 2.30730548 |
| 76 | Abnormal gallbladder physiology (HP:0012438) | 2.30068405 |
| 77 | Cholecystitis (HP:0001082) | 2.30068405 |
| 78 | Metabolic alkalosis (HP:0200114) | 2.25930010 |
| 79 | Generalized aminoaciduria (HP:0002909) | 2.25552375 |
| 80 | Purpura (HP:0000979) | 2.21827656 |
| 81 | Enlarged kidneys (HP:0000105) | 2.21748086 |
| 82 | Sensorimotor neuropathy (HP:0007141) | 2.21662154 |
| 83 | Late onset (HP:0003584) | 2.18064285 |
| 84 | Amyloidosis (HP:0011034) | 2.17521674 |
| 85 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.16974770 |
| 86 | Pancreatitis (HP:0001733) | 2.16022356 |
| 87 | Esophageal varix (HP:0002040) | 2.15701327 |
| 88 | Vomiting (HP:0002013) | 2.15278628 |
| 89 | Pulmonary embolism (HP:0002204) | 2.14690996 |
| 90 | Gingival bleeding (HP:0000225) | 2.11391089 |
| 91 | Alkalosis (HP:0001948) | 2.09999915 |
| 92 | Abnormality of vitamin metabolism (HP:0100508) | 2.09997866 |
| 93 | Rickets (HP:0002748) | 2.08728466 |
| 94 | Brushfield spots (HP:0001088) | 2.08556929 |
| 95 | Hypokalemic alkalosis (HP:0001949) | 2.06573609 |
| 96 | Menorrhagia (HP:0000132) | 2.06126644 |
| 97 | Thrombophlebitis (HP:0004418) | 2.05346032 |
| 98 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03397712 |
| 99 | Opisthotonus (HP:0002179) | 2.02840330 |
| 100 | Proximal tubulopathy (HP:0000114) | 1.99509249 |
| 101 | Hydroxyprolinuria (HP:0003080) | 1.98492129 |
| 102 | Abnormality of proline metabolism (HP:0010907) | 1.98492129 |
| 103 | Abnormality of the gallbladder (HP:0005264) | 1.97458102 |
| 104 | Hyperactive renin-angiotensin system (HP:0000841) | 1.96716401 |
| 105 | Hyperuricemia (HP:0002149) | 1.94875305 |
| 106 | Increased purine levels (HP:0004368) | 1.94875305 |
| 107 | Hemorrhage of the eye (HP:0011885) | 1.94860155 |
| 108 | Poikilocytosis (HP:0004447) | 1.93420063 |
| 109 | Facial shape deformation (HP:0011334) | 1.92881150 |
| 110 | Potter facies (HP:0002009) | 1.92881150 |
| 111 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.92701447 |
| 112 | Hypophosphatemic rickets (HP:0004912) | 1.92590007 |
| 113 | Hypophosphatemia (HP:0002148) | 1.89035362 |
| 114 | Abnormal cartilage morphology (HP:0002763) | 1.88852434 |
| 115 | Renal cortical cysts (HP:0000803) | 1.86408337 |
| 116 | Abnormal platelet function (HP:0011869) | 1.85535779 |
| 117 | Impaired platelet aggregation (HP:0003540) | 1.85535779 |
| 118 | Abnormality of iron homeostasis (HP:0011031) | 1.85014383 |
| 119 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84967440 |
| 120 | Glycosuria (HP:0003076) | 1.83402683 |
| 121 | Abnormality of urine glucose concentration (HP:0011016) | 1.83402683 |
| 122 | Cerebral palsy (HP:0100021) | 1.74174366 |
| 123 | Increased serum ferritin (HP:0003281) | 1.73670919 |
| 124 | Abnormal urine output (HP:0012590) | 1.73180530 |
| 125 | Abnormality of the Achilles tendon (HP:0005109) | 1.70528077 |
| 126 | Generalized hypopigmentation of hair (HP:0011358) | 1.70506197 |
| 127 | Joint swelling (HP:0001386) | 1.70478405 |
| 128 | Hypomagnesemia (HP:0002917) | 1.69864978 |
| 129 | Arthropathy (HP:0003040) | 1.63209961 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.24771597 |
| 2 | FGFR4 | 4.59706519 |
| 3 | SIK1 | 4.42756393 |
| 4 | ERN1 | 4.34140810 |
| 5 | INSRR | 3.03679022 |
| 6 | TAOK3 | 3.00849519 |
| 7 | ERBB4 | 2.97188966 |
| 8 | MAP2K4 | 2.27523572 |
| 9 | MST1R | 2.16114136 |
| 10 | PKN2 | 2.16006423 |
| 11 | MAPK11 | 1.92034143 |
| 12 | PIK3CG | 1.84334302 |
| 13 | FLT3 | 1.83804679 |
| 14 | TRIB3 | 1.73309612 |
| 15 | LATS1 | 1.69229326 |
| 16 | TYK2 | 1.64506244 |
| 17 | PIK3CA | 1.52612749 |
| 18 | PTK6 | 1.48467658 |
| 19 | ABL2 | 1.47905740 |
| 20 | DAPK2 | 1.45453488 |
| 21 | FRK | 1.41892658 |
| 22 | NTRK3 | 1.40081587 |
| 23 | FGFR2 | 1.38839465 |
| 24 | NEK9 | 1.38385151 |
| 25 | PDK2 | 1.37750673 |
| 26 | ACVR1B | 1.34790803 |
| 27 | MAP3K7 | 1.24805710 |
| 28 | JAK2 | 1.22330741 |
| 29 | MAP3K12 | 1.21841469 |
| 30 | KDR | 1.21508443 |
| 31 | PINK1 | 1.18077872 |
| 32 | STK39 | 1.17899827 |
| 33 | STK38L | 1.17061109 |
| 34 | PRKAA2 | 1.12965842 |
| 35 | NLK | 1.10685415 |
| 36 | GRK6 | 1.06546748 |
| 37 | MAP3K14 | 1.01561742 |
| 38 | MAP2K3 | 1.01449749 |
| 39 | ERBB2 | 1.01416829 |
| 40 | JAK1 | 0.99304580 |
| 41 | TBK1 | 0.99022026 |
| 42 | FER | 0.93504586 |
| 43 | MAPK15 | 0.93436848 |
| 44 | MAPK4 | 0.93413438 |
| 45 | PRKCZ | 0.93217193 |
| 46 | MAP3K10 | 0.92640390 |
| 47 | ADRBK2 | 0.90988270 |
| 48 | MAP3K2 | 0.88485668 |
| 49 | MAP3K3 | 0.87047291 |
| 50 | EPHB1 | 0.86807690 |
| 51 | MET | 0.85192631 |
| 52 | KSR2 | 0.83026927 |
| 53 | PRKACA | 0.79788679 |
| 54 | TIE1 | 0.79699444 |
| 55 | MAPK12 | 0.76699294 |
| 56 | PRKACG | 0.75371771 |
| 57 | CDK6 | 0.75192916 |
| 58 | DYRK1B | 0.74275930 |
| 59 | GSK3A | 0.73145635 |
| 60 | SGK3 | 0.72723170 |
| 61 | EPHA3 | 0.71200287 |
| 62 | PRKAA1 | 0.70566894 |
| 63 | MAP3K11 | 0.69886540 |
| 64 | CAMK2G | 0.69120376 |
| 65 | PRKG1 | 0.68840646 |
| 66 | MYLK | 0.66563185 |
| 67 | CSK | 0.66180218 |
| 68 | IRAK3 | 0.66162927 |
| 69 | CAMK1D | 0.64100491 |
| 70 | MAP2K6 | 0.62318260 |
| 71 | WNK3 | 0.60754935 |
| 72 | FGFR3 | 0.59513993 |
| 73 | PTK2 | 0.59044264 |
| 74 | TGFBR2 | 0.58960493 |
| 75 | RIPK1 | 0.57841877 |
| 76 | SGK2 | 0.57318187 |
| 77 | WNK4 | 0.56708608 |
| 78 | MAPK7 | 0.54746093 |
| 79 | PRPF4B | 0.54165787 |
| 80 | PDPK1 | 0.53504265 |
| 81 | TNK2 | 0.52797353 |
| 82 | STK38 | 0.52706140 |
| 83 | SGK494 | 0.52357311 |
| 84 | SGK223 | 0.52357311 |
| 85 | CSF1R | 0.51622776 |
| 86 | PRKCB | 0.50422401 |
| 87 | IKBKE | 0.49358253 |
| 88 | PRKCQ | 0.49054905 |
| 89 | SGK1 | 0.48630569 |
| 90 | CSNK1G1 | 0.47038521 |
| 91 | PRKCE | 0.45566783 |
| 92 | EPHA4 | 0.45119033 |
| 93 | TXK | 0.45113716 |
| 94 | ARAF | 0.44278014 |
| 95 | IGF1R | 0.43243002 |
| 96 | PDK4 | 0.42846152 |
| 97 | PDK3 | 0.42846152 |
| 98 | BMX | 0.42256175 |
| 99 | PRKG2 | 0.41411292 |
| 100 | MAP3K5 | 0.41293474 |
| 101 | RPS6KA3 | 0.40811089 |
| 102 | PKN1 | 0.40283264 |
| 103 | GRK1 | 0.39613853 |
| 104 | PRKACB | 0.39507933 |
| 105 | RET | 0.39332992 |
| 106 | MUSK | 0.39001274 |
| 107 | CSNK1A1 | 0.38945845 |
| 108 | MAP2K1 | 0.38680330 |
| 109 | PRKCG | 0.38491147 |
| 110 | TAOK2 | 0.37783109 |
| 111 | ICK | 0.37735850 |
| 112 | MAP3K13 | 0.36266977 |
| 113 | SRC | 0.35896741 |
| 114 | OXSR1 | 0.34689754 |
| 115 | KIT | 0.34419352 |
| 116 | CDK4 | 0.34394779 |
| 117 | MTOR | 0.34254873 |
| 118 | ZAP70 | 0.34027092 |
| 119 | CAMKK1 | 0.33671522 |
| 120 | MAP3K6 | 0.33393531 |
| 121 | SCYL2 | 0.33209771 |
| 122 | PDK1 | 0.33105815 |
| 123 | EGFR | 0.32229139 |
| 124 | CSNK1D | 0.32172930 |
| 125 | CAMK4 | 0.29026639 |
| 126 | CDK9 | 0.28522020 |
| 127 | CAMKK2 | 0.27964904 |
| 128 | MAP3K9 | 0.27807619 |
| 129 | AKT3 | 0.27557931 |
| 130 | PBK | 0.27442166 |
| 131 | IRAK1 | 0.26962375 |
| 132 | IRAK2 | 0.26760158 |
| 133 | PRKCA | 0.26088443 |
| 134 | CSNK1G2 | 0.25821529 |
| 135 | CAMK1G | 0.24276684 |
| 136 | MAP3K1 | 0.24051562 |
| 137 | PAK3 | 0.23463587 |
| 138 | LATS2 | 0.21969957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.49305702 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.54613982 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.39306576 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.38568885 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.02614024 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73881439 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.69219056 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.68678720 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67526300 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51294136 |
| 11 | * Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.44040913 |
| 12 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.35502491 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.30323990 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.24289962 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.13172906 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.13132416 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.01156334 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.92760861 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91734657 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.90543809 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89590551 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85292967 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81883106 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75196541 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.74093236 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73834555 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69473827 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68680934 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68427445 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66238909 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.62142946 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57807402 |
| 33 | * Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.57633933 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56754040 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.51649447 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44472455 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43015914 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41918708 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37144102 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31622044 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29817502 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20646476 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20305696 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.19100218 |
| 45 | * Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17846512 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16673335 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15965976 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11353464 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.09260173 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08275166 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03536120 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98909978 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95525138 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94929034 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94580113 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91148735 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90478119 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86098437 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.84930738 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74448440 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72609336 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70261634 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68734544 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56962491 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56283504 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49882183 |
| 67 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.46405656 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40312534 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.36126430 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25881479 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25666625 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25284942 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.22751840 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21705211 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.20955947 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20435598 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19370343 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14652619 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.10118533 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09721011 |
| 81 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.02197545 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01711207 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2419360 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2397994 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | -0.2386243 |
| 86 | Bladder cancer_Homo sapiens_hsa05219 | -0.2382850 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2331824 |
| 88 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2174069 |
| 89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1957083 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1923990 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1893425 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1808642 |
| 93 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1800418 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1737699 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | -0.1728668 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1674923 |
| 97 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1632276 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1617617 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1573981 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1471931 |
| 101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1319365 |
| 102 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1292307 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1084241 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1003054 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0827846 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0745768 |
| 107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0687413 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0420935 |
| 109 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0268136 |

